To evaluate the weight loss outcomes of the large U.S. cohort of patients undergoing endoscopic sleeve gastroplasty (ESG) with or without concomitant anti-obesity (AOM) use. We performed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback